key: cord-0010134-axerq16a
authors: Miller, Sara E.; Howell, David N.
title: Viral infections in the acquired immunodeficiency syndrome
date: 2005-02-04
journal: J Electron Microsc Tech
DOI: 10.1002/jemt.1060080105
sha: c8a3685ac605f31d2606a47f8c04b1453f9d6688
doc_id: 10134
cord_uid: axerq16a

The following communication is a tripartite synopsis of the role of viral infection in the acquired immunodeficiency syndrome (AIDS). The first section describes the impact of viral opportunistic infection in AIDS; for each virus, clinical presentation and diagnosis, laboratory diagnostic approaches (with emphasis on electron microscopy), and therapeutic interventions attempted to date are discussed. The second segment explores current theories on the pathogenesis of AIDS, and describes diagnostic and therapeutic approaches to the syndrome itself. The final section catalogues ultrastructural anomalies in the cells of AIDS patients, many of which have been mistakenly identified as etiologic agents.

Viruses occupy a unique position in the pathogenesis of acquired immunodeficiency syndrome (AIDS), representing not only the primary etiologic agent of the disease but also a major cause of associated opportunistic infection. Antiviral therapy is thus of central importance to the palliative treatment and eventual cure of AIDS. Because of the profound deficiency of cell-mediated immunity that typifies the AIDS patient, viruses normally eliminated or kept at bay in the immunocompetent host become overwhelming. We are approaching an era in which therapy for viral agents will be as commonplace as is that for bacteria. As more and more agents are found to be effective against viral infections, precise identification of the causative viruses becomes increasingly essential. Several drugs with proven antiviral efficacy in patients without immunocompromise have been used with some success in individuals with AIDS. Though perpetual maintenance therapy is generally required in such patients to prevent recrudescence of viral infection, improved quality and prolongation of life have been attained in many instances. It is for these reasons that we present a discussion of the virus diseases seen in AIDS patients, along with their clinical presentation, diagnosis, and treatment.

General methods for virus isolation and laboratory diagnosis of viral diseases have been described (Hsiung, 1982; Malherbe and Strickland-Cholmley, 1980; Rothchild and Cohen, 1986; White and Fenner, 1986) . Detailed methods for detection and identification of viruses by electron microscopy (EM) have been published (Miller, 1986; Doane and Anderson, 1987) . Virus concentration procedures and identification of AIDS-related viruses will be described briefly here.

Several of the viruses carried by AIDS p a tients, including hepatitis B virus (HBV) and human immunodeficiency virus (HlV) itself, are capable of infecting immunocompetent individuals. As will be discussed below, the tissue distribution of these viruses is extremely diverse; HIV has been isolated from bodily fluids from a number of sites as well as from leukocytes. Therefore, all samples from suspected AIDS cases must be treated with extreme care. Gloves should be worn routinely during all processing steps prior to fixation. Specimens should be processed in a biohazard hood if possible; if not, in a quiet corner away from traffic and on a piece of plastic-backed absorbent paper. Extreme care must be taken to prevent creation of aerosols. All disposables must be autoclaved before discarding, and all tools and containers must be disinfected. Easily available disinfectants are 10% Clorox or 70% ethanol (FDA, 1985) .

If the specimen is liquid (e.g., cerebrospinal fluid [CSF] , blood, urine, stool suspension, blister fluid, tears, lavages), it is centrifuged at low speed (1,500g) to remove cells and large debris. A drop of sample is placed on parafilm, and a formvar-and carbon-coated membraned grid is allowed to sit on top of the drop for 5-10 min. The grid is then drained with filter paper and transferred to a drop of 2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for 2-5 min; it is then washed by touching three drops of distilled water, and drained again. This fixation step is not necessary to preserve virus structure, but it is recommended for all samples from AIDS patients as a means of killing pathogenic viruses, since infectious virions can survive negative staining. In the absence of a fixation step, the grid and microscope specimen holder must be properly disinfected after viewing. Negative staining is accomplished by placing the washed, drained grid onto a drop of aqueous, saturated uranyl acetate or 1% phosphotungstate for 30-60 sec and draining. Under no circumstances should the sample be mixed with negative stain and atomized onto the grid. Many samples contain virus at a high enough titer to allow demonstration by the simple, fast, and direct method described above. Viruses present at lower concentrations can frequently be detected by utilizing one of the liquid sample concentration techniques that we have previously described (Miller, 1986) . Briefly, after low-speed debris clarification, the virus can be pelleted by ultracentrifugation for 1 hr at 100,OOOg or airfuge ultracentrifugation (Beckman Instruments, Fullerton, CA) at 30 lbhq in (100,OOOg) for 30 min. The pellet is then resuspended in the remaining drop after decanting the supernatant into disinfectant, and the drop is placed on a grid as described above. If an EM rotor is used in the airfuge, the sample can be pelleted directly onto the grid. Low-speed centrifugation with an ul-trafiltration device designed to retain particles 20 nm or greater in diameter (Schleicher and Schuell, Keene, NH) is an alternative means of concentrating virus particles.

Specific antibodies or pooled gamma globulin, which may contain virus-reactive antibodies, can be added to virus suspensions to clump and concentrate virus particles (Almeida, 1980; Kapikian et al., 1976) . Final antibody dilutions should be in the range of 1:lOO-1:1,000. After incubation for 30 min at 37°C or overnight at 4"C, the suspension is pelleted at 15,OOOg for 1 hr. The pellet is then resuspended in the small drop remaining after decanting the supernatant and placed on a grid as described above.

The pseudoreplica technique, originally described by Sharp (19601, is often used with urine suspected of containing cytomegalovirus (CMV). A drop of suspension is placed on an agar block, and the liquid is allowed to diffuse into the agar. A formvar solution is then dropped onto the block, floated off onto a water surface, and picked up on a grid. A similar technique places a grid on a drop of suspension on agar, and as the solution diffuses into the agar, the virus is concentrated onto the grid (Anderson and Doane, 1972) . If specific antibody is mixed with the agar, it will clump the viruses as they are concentrated onto the grid (Anderson and Doane, 1973) . The utility of specific antibody addition to the specimen is realized only if the researcher has some a priori idea of the possible agents present; if a specific agent is not suspected, pooled gamma globulin may be used in hope that it contains antibody against any viruses present.

Biopsies for ultrathin sectioning should be processed routinely (e.g., in 2% glutaraldehyde, 1% osmium tetroxide, and 1% uranyl acetate followed by embedment) (Hayat, 1981) . Rapid methods for embedment in less than 2 hr have been described (Miller, 1986) .

Occasionally, low virus concentration will preclude visualization by any of the previously discussed techniques. Allowing a round or two of virus replication in tissue culture can amplify viral numbers to a level detectable in the electron microscope (Miller and Lang, 1982) . Appropriate cell lines for inoculation are discussed by Miller (1986) . One must keep in mind that some viruses cannot VIRUSES be grown in conventional tissue culture.

Cytomegalovirus (CMV) infection, which is often asymptomatic in normal subjects (Sommerville, 1984) , is frequent and severe in AIDS patients (Quinnan et al., 1984) . Indeed, most of the literature on virus infections in individuals with AIDS pertains to CMV; postmortem studies show that 30-40% of these patients are infected with the virus. Frequent sites of infection are the lungs, central nervous system (CNS), retina, gastrointestinal (GO tract, reticuloendothelial system, kidneys, and adrenals (Guarda et al., 1984; Jensen et al., 1984; Rodrigues et al., 1983; Snider et al., 1983; Tucker et al., 1985) . The virus has been isolated from blood, saliva, urine, semen, uterine secretions, breast milk, and CSF (Drew et al., 1981; Edwards et al., 1985; El-Mekki et al., 1987; Quinnan et al., 1984; Stagno et al., 1980) . CMV interstitial pneumonitis is a major cause of morbidity and mortality in AIDS patients . Frequently, CMV and Pneumocystis carinii (see Sun and Teichberg, are found together, and CMV has been found in suspected P. carinii pneumonia cases that were negative for the protozoan (Barbour, 1987; Gorelkin et al., 1986) .

Bronchoscopic lavage has been successful in establishing the diagnosis of CMV pneumonitis in some cases (Golden et al., 19861, but open lung biopsy is recommended if bronchoscopy is negative (Barrio et al., 1987) . Unlike herpes simplex virus (HSV) and herpes zoster virus (HZV), CMV is not neurotropic and does not ordinarily cause neurological disease in immunocompetent individuals (Duchowny et al., 1979) . In immunocompromised hosts, however, it can cause either encephalomyelitis or demyelination without inflammation in both the central and peripheral nervous systems (Moskowitz et al., 1984; Tucker et al., 1985) . The mechanism by which demyelination occurs is unknown. Possibilities include viral cytotoxic effects on support cells, release of lytic factors from neighboring cells destroyed by the virus, and autoimmune attack secondary to crossreactivity between viral antigens and myelin or autosensitivity to damaged myelin. Other typical lesions include ventri-IN AIDS 43 culitis with periventricular destruction and cerebral or pituitary involvement (Hawley et al., 1983) and diffuse glial nodule encephalitis (Snider et al., 1983) . Neurological symptoms include encephalopathy, often with progressive dementia, occasional focal motor deficits, seizures, and headache and fever.

Computerized tomography (CT) of the head may be unrevealing in cases in which inflammation is minimal. Contrast CT scans are of potential value in this setting. A comparison of CT findings in different viral CNS diseases is presented by Sanvar et al. (1986) . Magnetic resonance imaging (MRD studies may be useful in the diagnosis of CMV CNS infection (Levy et al., 1985; Post et al., 1986) . However, definitive diagnosis rests with the identification of virus in biopsy material, occasionally in CSF, and often at autopsy (Petito et al., 1986; Tucker et al., 1985) .

CMV is the major cause of blindness in AIDS patients (Palestine et al., 1984) . CMV retinitis is characterized by rapidly progressive necrotic lesions, frequently with hemorrhage, which obliterate the retina within 6 months. On ophthalmoscopic examination, virus-induced white spots or granular patches are difficult to distinguish from "cotton wool spots." The latter occur in conditions of ischemia such as diabetes, hypertension, and anemia, and represent microinfarctions of nerve fibers. CMV lesions can be distinguished by their rapidly progressive nature and the presence of hemorrhage (Rodrigues et al., 1983) and by demonstration of the virus in tissue after globe removal or at autopsy (Holland, 1985; Jensen et al., 1984; Pepose et al., 1983) . HSV and toxoplasma can also cause retinitis and confuse the diagnosis (Neuwirth et al., 1982) . Color ophthalmoscope pictures by Rosecan et al. (1986) and De Venecia et al. (1971) demonstrate CMV retinal lesions. CMV retinitis is a poor prognostic sign in AIDS. It usually occurs late in the course of the disease; death frequently occurs within 6-8 weeks following the diag-' nosis of retinitis, regardless of the patient's medical status at its onset (Holland, 1985) . CMV can cause lesions throughout the GI tract, from the mouth to the anus, in AIDS patients. Alimentary CMV is often the first evidence of AIDS (Hinnant et al., 1986) . Manifestations include severe debilitating diarrhea, marked weight loss, fevers, stools positive for occult blood, and occasionally massive colonic hemorrhage or perforation (Frager et al., 1986) . Colonoscopy may show yellow maculopapular lesions (Levinson and Bennetts, 1985) . Radiographic and CT findings are not specific, and early lesions may not show up at all Frager et al., 1986) . The symptoms and endoscopic, colonoscopic, and radiographic findings in CMV GI disease can mimic those of other ailments, including tumors, inflammatory bowel disease with diffuse mucosal ulceration or granulomatous lesions, and other infectious processes (Elta et al., 1986; Frager et al., 1986; Freedman et al., 1985; Knapp et al., 1983) . Diagnosis by biopsy must be made to rule out treatable conditions such as candidiasis.

CMV can infect the adrenal glands, causing adrenal insufficiency and hypotension (Bleiweiss et al., 1986) . CMV hepatitis, cholangitis, cholecystitis, and pancreatitis have been described in AIDS patients (Galloway, 1984; Sacks and Freeman, 1984; Agha et al., 1986; Kavin et al., 1986) . Endocrine problems and hypercalcemia have also been seen as a result of CMV infection of the parathyroid glands (Zaloga et al., 1985) .

A final site requiring comment with regard to CMV-related disease in AIDS patients is the skin. The primary cutaneous manifestation of CMV in AIDS is its proposed role as a n etiologic agent in Kaposi's sarcoma (KS), a neoplasm that presents as raised, reddishpurple lesions of skin and occasionally viscera (see Tucker, . The link between CMV and KS is circumstantial but strong. In the absence of global, severe immunosuppression (as seen in late-stage AIDS), several studies have documented increased titers of antibody to CMV, but not Epstein-Barn virus (EBV) or HSV type 1 (HSV-1) or type 2 (HSV-2) in patients with KS (Drew, 1986; Giraldo et al., 1984) . The virus itself has been isolated from KS tumor biopsies (Giraldo et al., 1984) , and CMV DNA, mRNA, and nuclear antigen have been demonstrated in tumor tissue Greenspan and Shillitoe, 1984; Fenoglio et al., 1982) . CMV is known to be oncogenic in vitro; it can initiate cellular DNA, RNA, and protein synthesis, and its genome can induce transformation of cultured cells (Giraldo and Beth, 1986; Rapp, 1984) . The virus has also been linked with adenocarcinoma of the colon (Huang and Roche, 19781, prostatic cancer (Sanford et al., 19771, and cervical cancer (Melnick et al., 1978) . The exact role of CMV in KS tumorigenesis is unclear. It is not known if the virus acts directly via a viral onc gene product, recom-bines with or alters the host genome, or provides continuing immunosuppression enabling a n emerging tumor to escape surveillance (Spector and Spector, 1984) .

The argument in favor of CMV as an etiologic factor in KS is not without contradiction. Dotz and Berman (1983) have described KS patients with positive antibody titers against HSV in the absence of anti-CMV antibodies. HBV has been demonstrated in KS tissue as well as CMV (Siddiqui, 1980) . However, the bulk of the evidence accumulated to date suggests that CMV plays a part in the etiology of KS.

CMV has been reported only sporadically as a causative factor in non-neoplastic cutaneous disease. In one case, the virus was demonstrated in unusual purpuric skin lesions in a patient with AIDS (Penneys and Hicks, 1985) . The authors of this report stressed the importance of distinguishing such lesions from the papular lesions seen in poxvirus infections (see below).

Numerous diagnostic modalities have been applied to the detection of CMV (Doerr et al., 1985) . Routine serologic analysis of circulating anti-CMV antibodies by radioimmunoassay (RIA) or enzyme-linked immunosorbant assay (ELISA) (Griffiths, 1985; Kiefer et al., 1983; McKeating et al., 1985; Nath et al., 1987) is of little value in AIDS patients. Immunosuppressed patients frequently fail to mount a serologically detectable antibody response to CMV (Doerr et al., 1977) . Conversely, a majority of healthy adults possess circulating IgG antibodies to CMV, though the appearance of IgM anti-CMV antibodies may correlate with active viral disease.

Immunochemical detection of CMV and its components has been used with some success. An RIA with monoclonal antibodies has been described for detecting the agent (Goldstein et al., 19821, as have ELISAs (El-Mekki et al., 1987; McKeating et al., 1985; Yolken and Stopa, 1980 ). An immunofiltration technique (a modified ELISA) that is faster and simpler than, and almost as sensitive as, DNA hybridization has been described (Rossier et al., 1987) . These techniques have the theoretical drawback of potentially failing to detect serological variants of the virus and depend heavily on the sensitivity and specificity of the antibodies employed.

Viral culture can be used to detect CMV, both as a diagnostic technique in its own right and as a n amplification step prior to EM (Miller, 1986) . Culturing of CMV, though particularly useful when virus is present at low concentration, has the disadvantage of being extremely time-consuming; detectable growth may require 2-6 weeks (Bach, 1986; Doerr et al., 1985; Tucker et al., 1985) . Detection may be enhanced by low-speed centrifugation in special tissue culture vials (Gleaves et al., 1985) .

Light microscopy (LM) is a useful means of detecting the presence of CMV infection, and has the additional potential of revealing concomitant infections with other organisms, a frequent occurrence in patients with AIDS.

By LM, the nuclei of CMV-infected cells often exhibit an "owl's eye" morphology, consisting of dense intranuclear viral inclusions surrounded by a clear halo and dense marginated chromatin at the nuclear membrane (Knapp et al., 1983; Nash, 1982) . Cytoplasmic inclusions may also be present. The intranuclear inclusions are best demonstrated on routine hematoxylin and eosin (H & El-stained (Meiselman et al., 1985) or Papanicolaou-stained (Schulman et al., 1982) sections. Gomori's methenamine silver and the periodic acid-Schiff reaction, frequently used in the diagnosis of l? carinii and fungal infection, stain cytoplasmic but not intranuclear CMV inclusions and are thus of limited value in the diagnosis of CMV infection (Gorelkin et al., 1986) . Excellent color (Malherbe and Strickland-Cholmley, 1980 ) and black and white (Hsiung, 1982) micrographs of CMV-infected cells have been published.

Immunofluorescence microscopy has been used to demonstrate CMV in lung lavage specimens (Emanuel et al., 19861, transbronchial biopsies (Blumenfeld et al., 1984) , and liver tissue (Sacks and Freeman, 1984) ; immunoperoxidase staining of CMV has likewise been reported for brain and spinal cord tissue (Tucker et al., 1985) . These techniques, though rapid (Hackman et al., 1985) , carry the same caveats mentioned in connection with immunoassays for soluble CMV antigens.

In situ hybridization with CMV nucleic acid probes has also proven to be a useful adjunct in the diagnosis of CMV infection in tissue and urine specimens. This technque is capable of detecting latently infected cells (Chou and Merigan, 1983; Myerson et al., 1984; Spector and Spector, 1985) . It has been used to demonstrate CMV in colonic tissue that was negative for the virus on routine histologic and immunofluorescence examination (Roche et al., 1981) . Hybridization can be performed on formalin-fixed, paraffinembedded tissue after years of storage (Myer-son et al., 1984) . EM has been used with considerable success in the diagnosis of CMV infection in both tissues and bodily fluids, especially urine. In EM examination of thin sections, spherical nucleocapsids of 100 nm are seen, mostly in the nucleus where they are constructed (Fig. lc) ; some naked particles may escape into the cytoplasm before they obtain their outer membrane. Nucleocapsids receive their outer covering by budding through the nuclear membrane, sometimes through internal membranes into vesicles and sometimes through the cytoplasmic membrane. The whole virion may be 150-200 nm in diameter ( Fig. la,b ) Nufioz et al., 1987; Rodrigues et al., 1983) . Because of the pliable, nonornamented outer covering, the virion may be difficult to distinguish from cellular debris in negative stains unless the stain penetrates the membrane and outlines the icosahedral nucleocapsid (Fig. ld,e) . CMV cannot be distinguished by EM from other members of the herpes family.

Therapy for CMV infections in AIDS patients has been generally unsatisfactory. The greatest experience to date has been with 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG), an acyclovir analog. DHPG, also known variously as BW B759U, gancicyclovir, ganciclovir, B'NDG, and B10LF-62, has been used with some success in the treatment of CMV pneumonia (Collaborative DHPG Treatment Study Group, 1986; Laskin et al., 1987) , CNS infections, and retinitis (Bach, 1986; Humphrey et al., 1986; Palestine et al., 1986; Rosecan et al., 1986) . Though some AIDS patients have experienced prolonged survival and improved quality of life as a result of this therapy (Kotler et al., 19861 , discontinuation of the drug has invariably led to a recrudescence of CMV infection. DHPG therapy has also been complicated by bone marrow suppression and neutropenia in some cases (Barbour, 1987; Holland et al., 1986) .

Phosphonoformate (PFA, Foscarnet) has been used with some success in the treatment of CMV retinitis, and may require a less frequent maintenance regimen than DHPG (Singer et al., 1985) . Other agents, such as acyclovir (acycloguanosine, Zovirax) (Bach, 1986) , vidarabine (adenine arabinoside [ara-A]) (Bach, 1986) , and cytarabine (cytosine arabinoside [ara-C]), alone and in combination with interferon (Furio and Wordel, 1985) , have been of little therapeutic benefit in CMV infection. Alpha interferon has been used in the treatment of KS in AIDS patients with a 40% success rate. It appears to act as an antineoplastic agent rather than as an immune modulator (Volberding et al., 1984) . Other agents that have been used with some reported success include etoposide, vinblastine, and a combination of doxorubicin, bleomycin, and vinblastine (Krigel, 1984 

Herpes simplex virus (HSV) types 1 and 2 can both cause encephalitis, meningitis, and myelitis with immune-mediated demyelination (Britton et al., 1985; Handler and Perkin, 1982; Heller et al., 1982; Maier et al., 1986; Nahmias et al., 1982) as well as eye (Pepose et al., 1985) and skin lesions (Siegal et al., 1981) . HSV hepatitis is rare but does occur in immunocompromised patients (Chase et al., 1987) .

HSV encephalitis (HSE) has a propensity for involving one or both temporal lobes (Weiner and Fleming, 1984) . Presentations include fever, headache, stiff neck, clouded consciousness, and focal neurologic signs, including seizures, aphasia, and focal motor and sensory deficits. Mortality from HSE is correlated with the level of consciousness at the initiation of antiviral therapy in immunocompetent hosts. In AIDS patients, the rapidity of progression of the disease is proportional to the severity and degree of immune suppression. HSE must be distinguished diagnostically from cryptococcosis, tuberculosis, and bacterial abscesses, all of which may have similar clinical presentations (Hirsch and Schooley, 1983b) . CT and electroencephalography (EEG) may suggest temporal lobe lesions; radionuclide scans may Figs. 1-11. Lower-magnification ( x 20,000) micrographs of virus-infected cells illustrate the relationship of the viruses to the cells. High magnification ( x 100,000) of both thin sections and negative stains of viruses shows virion ultrastructure; all viruses are printed at the same magnification to permit direct comparison of size. Micrographs of virus-like structures are reproduced so that they are presented here at the same final magnification for comparison. The magnification selected (~50,000) is that which is the closest to the majority of the original micrographs. They are 2% times the size of the infected cell micrographs and % the size of the virion micrographs. High magnification of complete membraned virions (arrow) in the cytoplasm. c: High magnification of nucleocapsids (arrows) in the nucleus. d,e: Negatively stained CMV. d The pleomorphic complete particle (large arrowhead) is nondescript and would not be identifiable in a field of cell membrane debris. The nucleocapsid (small arrowhead) has lost its outer covering; it is damaged so that the stain has penetrated the capsid coat. e: The membrane (large arrowhead) still surrounds the nuclsocapsid (small arrowhead) but has been broken so that stain penetrated and outlined the nucleocapsid. Bar in a = lpm; bars in b-e = 100 nm. Figures a-c are reprinted from Gorelkin et al. (1986) with permission from the W.B. Saunders Co. provide improved detection of such lesions (Weiner and Fleming, 1984) , as may MRI (Schroth et al., 1987) . The presence of temporal lobe involvement is strongly suggestive of HSE, but in one study, one-half of a series of clinically suspected HSE cases were eventually shown to have other etiologies (Nahmias et al., 1982) . As with CMV, definitive diagnosis requires demonstration of the virus or viral antigens in biopsy tissue, CSF, or aspirates.

Most HSV retinitis is associated with encephalitis. In contrast to CMV retinitis, the lesions of which resemble ischemic cotton wool spots, HSV retinitis is characterized by retinal edema, hemorrhage, and perivasculitis. In advanced stages, a hazy yellow-white necrotic retina progresses to exudative retinal detachment (Pepose et al., 1985) .

Serological methods for detecting active HSV infection have been described (Doerr et al., 1987) ; however, as in the case of CMV, they are of limited value in AIDS patients, since a majority of healthy individuals are seropositive for HSV, and immunosuppressed patients with HSV infections are frequently seronegative. LM of H & E-stained sections of HSV-infected tissue shows diffuse basophilic and contracted eosinophilic intranuclear inclusions, sometimes with marginated chromatin (Malherbe and Strickland-Cholmley, 1980) . Immunoperoxidase staining of tissue sections fixed with Bouin's fixative rather than formalin has also been used to demonstrate the inclusions (Pepose et al., 1985) . HSV-and CMV-infected cells are frequently similar in appearance, though the latter are often larger, with inclusions occupying a greater percentage of the nucleus.

Unlike CMV, HSV causes characteristic cytopathologic effects (CPE) in tissue culture, consisting of a shift to rounded cellular morphology followed by rapid destruction of the cell monolayer within 1-2 days (Hsiung, 1982) . A rapid identification technique has been described for HSV-1 and HSV-2 that makes use of centrifugation in shell vials (originally described for C M Y by Gleaves et al., 1985) and staining with fluoresceinated monoclonal antibodies. Detection and typing can be accomplished in 1-2 days (Winter et al., 1987) . A method for rapid identification of HSV has been described using amplification in tissue culture and identification by EM (Miller and Lang, 1982) . In the electron microscope, thin sections of HSV-1 (Fig. 2) and HSV-2 ( Fig. 3) resemble CMV (Fig. 1) . Nucleocapsids of 100 nm may be seen in the nucleus or cytoplasm (Fig. 2a,b) , and complete membraned virions (Fig. 2c) can be seen budding from the nuclear membrane, into cytoplasmic vesicles, or from the cytoplasmic membrane (Fig. 2a) . Redundant membrane production is characteristically seen in herpesvirus-infected cells (Fig. 2a) . Tubular structures are occasionally seen within the nuclei of cells infected with HSV-2 ( Fig. 3 ) (Fong and Hsiung, 19781 , but not HSV-1. A negative stain of blister fluid may reveal the 100-nm icosahedral nucleocapsid if the membrane has been broken (Fig. 2d) . Though HSV-1 and HSV-2 cannot generally be differentiated from each other or from HZV in negatively stained preparations, herpesviruses and poxvirus, the agent of molluscum contagiosum, can be distinguished readily.

Acyclovir is currently the drug of choice for the treatment of HSV infections (Hirsch and Schooley, 198313; Whitley et al., 1987) . Intravenous acyclovir has been used with success in the treatment of HSE in immunocompetent patients (Levy et al., 1985) and has also been used to manage HSV infections in patients with AIDS (Barbour, 1987) . Intravenous vidarabine decreases the mortality of HSE from 70% to 28% in nonimmunocompromised hosts. Since the large volume of intravenous fluid required for vidarabine administration may engender brain edema, brain biopsy is recommended to establish the necessity for treatment (Furio and Wordell, 1985; Pepose et al., 1985) . Oral acyclovir may prove beneficial as prophylaxis for HSV infection in immunocompromised hosts (Fiddian, 1987; Hirsch and Schooley, 198313) . Topical acyclovir for HSV mucocutaneous lesions shortens the time to resolution in firstepisode infections but is less effective for recurrent disease (Mindel et al., 1987) . Intravenous acyclovir is also effective for serious skin lesions (Hirsch and Schooley, 1983b) . Ocular HSV keratitis can be treated with topical trifluorothymidine and vidarabine (Hirsch and Schooley, 1983b) . Other nucleic acid analogs, such as bromovinyldeoxyuridine (BVDU), chloroethyldeoxyuridine (CEDU), and fluoroiodoaracytosine (FIAC) are promising new topical drugs for herpetic keratitis (De Clerq, 1986). Negatively stained virion; note that the stain has penetrated the membrane (large arrowhead) allowing visualization of the capsomers (petite arrowheads) but has not penetrated the interior of the nucleocapsid. Compare to negatively stained CMV. Bar in a = 1 pm; bars in b-d = Fig. 3 . One intranuclear HSV-2 nucleocapsid and filaments characteristic of HSV-2, but not HSV-1 infection. Bar = 100 nm. Reprinted from Fong and Hsiung (1978) , with permission from the CRC Press, Inc. glia, and may reactivate later. Reactivation often takes the form of shingles, a painful vesicular skin rash resulting from a deficiency in T cell or killer cell activity that is frequently seen in elderly patients. Shingles may be accompanied by neurological complications, including postherpetic neuralgia, paresis, and meningoencephalitis.

In immunocompromised patients, disseminated HZV infection may occur, with GI, pulmonary, and nervous system involvement (Friedman-Kien et al., 1986) . HZV CNS infection in individuals with AIDS may take the form of a hemorrhagic, necrotizing encephalitis with early symptoms of headache, fever, seizures, and aphasia. HZV also causes shingles in AIDS patients, and it may be an early clinical indicator of impending AIDS in those at risk (Cone and Schiffman, 1984; Payne et al., 1984; Friedman-Kien et al., 1986) . HZV infection of the eye in young adults is a marker for AIDS (Cole et al., 1984; Levy et al., 1985; Sandor et al., 1986) . HZV has also been reported in biopsies of hairy leukoplakia (HL) lesions , and it has been isolated from lung tissue without histological evidence of pulmonary infection (Ryder et al., 1986) .

Laboratory diagnostic approaches to HZV infection are similar to those utilized in other herpesvirus infections, including culture, LM with and without immunoperoxidase staining, Southern blot hybridization, and EM (Doerr et al., 1987; Gilden et al., 1987; Ryder et al., 1986) . LM examination may reveal intranuclear and cytoplasmic inclusions difficult to distinguish from those seen in HSV infection (Hsiung, 1982; Malherbe and Strickland-Cholmley, 1980) ; immunostaining may aid in this differentiation. By EM, typical herpes family nucleocapsids and membraned virions are evident in thin sections. HZV in negative stain resembles HSV but can be distinguished from poxvirus. Differentiation of HZV from other herpetic infections is important for the selection of proper drug therapy. DHPG, active against CMV infections, does not affect HZV; a higher concentration of acyclovir is required in HZV than in HSV infections (Murray, 1987) .

Intravenous vidarabine, acyclovir, and FIAC have been used in the treatment of HZV infection. These agents decrease cutaneous spread, accelerate pain resolution, and may prevent fatal dissemination, particularly if therapy is initiated within 72 hours of appearance of cutaneous lesions (Chang et al., 1987) . The efficacy of acyclovir is reportedly greater than that of vidarabine (Furio and Wordell, 1985; Shepp et al., 1986) . Additional therapeutic approaches currently under study include oral acyclovir, intramuscular vidarabine (Wood et al., 1987; Sherlock and Corey, 1985) , and new drugs, including BVDU and 6-deoxycyclovir (De Clercq, 1986) . In immunocompetent patients, prednisone decreases the severity and pain of HSV-induced lesions and reduces the likelihood of postherpetic neuralgia. However, corticosteroids may induce dissemination of HZV and are thus contraindicated in immunocompromised patients (Murray, 1987) . Corticosteroids may also predispose to disseminated CMV infection in AIDS patients (Armstrong et al., 1985; Gold, 1985) .

Epstein-Barr virus (EBV) has been implicated as an etiologic agent in Burkitt's lymphoma (a B cell lymphoma) in Africans (Epstein and Achong, 1977; Purtilo et al., 1985) . In Orientals, EBV has been associated with nasopharyngeal carcinoma (Klein, 1979) . In Americans and Europeans, its primary clinical importance is as the causative agent of infectious mononucleosis (Henle et al., 1968) . However, Burkitt's-like lymphomas have been reported in AIDS patients (see Tucker, , and EBV has been demonstrated in such lymphomas (Berman et al., 1985; Rosenberg et al., 1986; Whang-Peng et al., 1984) . Chromosomal translocations similar to those in Burkitt's lymphoma have been demonstrated in AIDS B cell lymphomas (Gyger et al., 1985; Lipscomb et al., 1983 Lipscomb et al., -1984 Petersen et al., 1985; Whang-Peng et al., 1984) . Possible factors predisposing patients with AIDS to EBVrelated malignancies include profound T cell immunodeficiency and abnormally high numbers of EBV-infected B cells (Birx et al., 1986; Purtilo et al., 1985; Sumaya et al., 1986) .

In addition to its posited etiologic role in B cell lymphoma, EBV has been linked circumstantially to several other conditions in AIDS patients. EBV antigens have been demonstrated in oral neoplasms, including squamous cell carcinoma and oral KS (Greenspan and Shillitoe, 1984; Ziegler et al., 1982) . The virus itself has been found in lungs of patients with lymphocytic interstitial pneumonia, in the brains of children with AIDS (Andiman et al., 19851 , and in biopsies of oral HL, a condition manifested by white flattened plaques on the sides and ventral sur-face of the tongue. The role of EBV in the pathogenesis of HL is unclear; by immunoperoxidase staining, tissue from HL plaques has also been shown in many cases to contain papillomavirus, and in some cases, HSV (Greenspan et al., , 1985 . The course of HL is variable; there may be spontaneous regression and recurrence. It is not known if the lesion is a premalignant condition, but since both herpesviruses and papillomaviruses have been implicated as possible causative agents, and since both have oncogenic capabilities, regular observation and biopsy is recommended (Youngs et al., 1986) . HL must be distinguished clinically from oral candidiasis, which may respond favorably to antifungal therapy.

The morphologic and biochemical identification of EBV, in contrast to the other members of the herpes family, plays a relatively minor role in the clinical diagnosis of EBVrelated complications in AIDS. The diagnosis of B cell lymphoma relies mainly on histology, immunohistochemistry, and occasionally, cytogenetics. Similarly, the presence of HL is generally confirmed histologically; by LM, the lesions resemble flat warts, with superficial whorls of fine keratin that are responsible for their "hairy" appearance.

EBV serology suffers from the same drawbacks as serological analysis of the other herpesviridae. High-titered anti-EBV antibodies are present in many healthy individuals and pregnant women; approximately one-half of all normal individuals tested exhibit some degree of seropositivity, presumably as a result of latent viral infection. Anti-EBV antibodies are also frequently found in recipients of organ transplants and patients with lymphoproliferative diseases. In contrast, some virus-positive individuals produce no serological response (Fackler et al., 1985) . Almost all AIDS patients exhibit elevated anti-EBV titers (Ciobanu and Wiernik, 1986; Rinaldo et al., 1986) , suggesting that many may harbor infections that are due to viral reactivation facilitated by immunosuppression.

Certain EBV antigens can be detected by immunohistologic analysis. Viral capsid antigen (VCA) is present during viral replication, and the Epstein-Barr nuclear antigen (EBNA) is also detectable in latently infected cells (Lindahl et al., 1974; Pearson et al., 1983) . Nucleic acid hybridization can also be used to detect the presence of EBV genomes in productively and latently infected cells (Andiman et al., 1983; Brandsma and Miller, 1980; Pi et al., 1983) . EM of cells productively infected with EBV reveals virus particles morphologically similar to the other herpesviruses. Virus particles have been demonstrated by EM in the lesions of HL, but EM is not a routinely useful diagnostic procedure for this disorder. EBV morphology and virus-induced CPE are described by Epstein and Achong (1979) .

In vitro, actively replicating EBV is sensitive to several antiviral agents, including a IF", vidarabine, phosphonoacetic acid, and acyclovir; but these drugs have no effect on latently infected cells. Acyclovir has been used with some success in the treatment of polyclonal B cell lymphoma, but not the monoclonal B cell lymphoma that often develops subsequently (Andersson et al., 1987; Hirsch and Schooley, 1983a) .

Hepatitis B virus (HBV) is widespread among homosexual men, intravenous drug abusers, and patients with AIDS, the latter of whom are generally seropositive for the virus . In spite of this fact, clinically overt liver disease is unusual in AIDS patients, a finding in keeping with the current concept that antiviral cellular immune responses play a major role in the pathogenesis of HBV hepatitis (Ray et al., 1976; Rustigi et al., 1984) . Hepatocellular carcinoma, which has been linked clinically (Romet-Lemonne et al., 1983 ) and experimentally (Griffiths, 1983) with HBV infection, has likewise not been seen with increased frequency in AIDS patients.

HBV infection is generally diagnosed by the serological detection of circulating viral antigens or antiviral antibodies (Omata et al., 1978; Barr and Mitchell, 1987; Hoar et al., 1985) . The virus can also be detected by nucleic acid hybridization techniques Romet-Lemonne et al., 1983; Scotto et al., 1983; Siddiqui, 1983; Yoffe et al., 1986) , sometimes in the absence of detectable HBV antibody or antigen (Hoar et al., 1985; Laure et al., 1985) .

Routine histologic analysis is useful in the clinical assessment of hepatitis in both its acute and chronic phases, though many of the histologic findings in HBV hepatitis are indistinguishable from those encountered in hepatitis caused by other viruses, drugs, and toxins (Huang and Fisher, 1987) . Histologic examination can be augmented by immunofluorescence analysis for hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) (Ray et al., 1976) .

HBV cannot be grown in conventional tissue culture. However, the levels of viremia often attained in acute infections (up to 1013 particles/ml; Griffiths, 1983 ) permit demonstration by EM, particularly after ultracentrifugation or immunoaggregation (see "Materials and Methods"). The infectious virus, or Dane particle, measures 42 nm in diameter and is roughly spherical; it is frequently accompanied by noninfectious 27-nmdiameter spherical and filamentous particles composed of viral capsid antigen (HBsAg) (Fig. 4c) . In liver tissue, aggregates of nondescript intracytoplasmic particles can be seen (Fig. 4a,b) .

Several antiviral agents, including vidarabine, acyclovir, and human leukocyte interferon, have been employed with variable success in the treatment of HBV infection. Response rates ranging from negligible to as high as 50% have been reported for vidarabine and interferon in studies involving immunocompetent patients (Thomas et al., 1987) .

Papovaviruses are associated with progressive multifocal leukoencephalopathy (PML), a subacute demyelinating disease seen in patients with lymphoproliferative, chronic granulomatous and immunosuppressive disorders. Symptoms of the disease include blurred vision, blindness, numbness, dizziness, hemiparesis, and ataxia (Levy et al., 1985) ; affected individuals are generally afebrile.

Two related papovaviruses have been implicated in the etiology of PML: J C virus (JCV), which has been found in most of the cases studied to date, and SV-40, a simian papovavirus, which has been isolated in a small number of cases (Zu Rhein, 1969; Coleman et al., 1978; Narayan et al., 1973) . JCV and BK virus (BKV), a third papovavirus whose etiologic role in PML has not been firmly established and which, like JCV, derives its name from the initials of the patient from whom it was first isolated, are frequently shed in the urine of transplant patients (Andrews et al., 1983; Hogan et al., 1980) and in the urine in late pregnancy or puerperium (Coleman et al., 1983) . A majority of healthy individuals have been exposed to these viruses by adolescence ). Fig. 4 . a: HBcAg particles in the cytoplasm of a n infected hepatic cell. b: Complete HBV virions (arrowheads) in the cytoplasm of a n infected cell. c: Negative stain showing infective Dane particles (arrowhead) and HBsAg in tubular and pleomorphic spherical forms. Bars = 100 nm. Reprinted from Huang and Fisher (1987) , with permission from the Williams and Wilkins Co.

The pathogenesis of PML is incompletely understood. The ubiquity of the associated papovaviruses in normal individuals suggests that the disease may represent a reactivation of latent infection rather than a primary infection (Krupp et al., 1985; Chesters et al., 1983) . PML occurs more frequently in AIDS patients, 2-4% of whom develop the disease, than in individuals with other immunosuppressive disorders. It has been proposed that HIV in the brain may have a direct effect on reactivation of latent papovaviruses (Stoner et al., 1986) .

On CT scans, the lesions of PML appear as hypodense areas in the white matter with cortical sparing. They frequently originate in one cerebral hemisphere, often with localization to the occipital lobe, and subsequently spread to involve the remainder of the brain. The presence of such lesions in the setting of a normal CSF examination is diagnostic for PML. Similar CT findings are occasionally encountered in toxoplasmosis, but cerebral infection with Toxoplasma is invariably associated with CSF perturbations (Weiner and Fleming, 1984) . In cases in which the diagnosis is uncertain, CT-directed needle biopsy can provide tissue for virological examination (Snider et al., 1983) .

Papovavirus infection can be detected by a number of techniques. Serology is not useful, since 70% of adults have antibodies against JCV, and patients with PML have no increase in titer over normal individuals (Brooks and Walker, 1984; Padgett and Walker, 1983) . However, both BKV and JCV have been detected by nucleic acid hybridization in renal tissue of PML patients (Chesters et al., 1983) . JCV is fastidious, but has been isolated in primary human fetal glial cells and urine-derived epithelial cells; BKV is less restrictive for host cells (Beckman and Shah, 1983) .

In spite of the availability of these techniques, the diagnosis of PML generally requires examination of involved brain tissue. Advanced lesions have necrotic centers containing numerous foamy phagocytic cells. At the peripheries of such lesions, enlarged, deformed astrocytes resembling malignant cells are found, and glial cells with intranuclear viral inclusions may be seen. A detailed description of the histopathology of PML is provided by Richardson et al. (1983) and McKeever et al. (1983) .

Fluorescence microscopy has been used to detect papovavirus antigens in brain tissue (Budka and Shah, 1983) . The immunohistology of PML is somewhat complex. Infected tissue is often reactive with antisera against JCV Narayan et al., 1973) . However, antibodies against the SV-40 T antigen also stain the nuclei of JCVinfected cells, occasionally in the absence of staining for other viral antigens. Both oligodendrocytes and astrocytes appear to be infected (Stoner et al., 1986) . The T antigen is destroyed by formaldehyde fixation, though the virus itself is stable. The antigen is preserved in acetone-fixed frozen sections.

By EM, the PML agents are 35to 40-nm spherical viruses, frequently associated with filaments 16-27 nm in diameter (Fig. 5a -c) Zu Rhein, 1969) . In negatively stained urine specimens, the viruses appear as 35-to 40-nm icosahedra (Fig. 5d,e) .

Treatment of PML has been attempted with vidarabine and cytarabine with some initial improvement but is unsatisfactory in AIDS patients (Krupp et al., 1985; Peters et al., 1980; Snider et al., 1983; Walker, 1978) .

Human papillomaviruses (HPV) cause condyloma acuminatum (venereal warts), a highly infectious, sexually transmitted disease (Ferenczy et al., 1985) , and have been associated with malignant transformation (Banks et al., 1987; Gupta et al., 1987a; McCance, 1987) . Some strains may give rise to dysplasia without warts (Frazer et al., 1986) . Perianal condylomata are common in homosexuals, and anorectal carcinoma has been reported in AIDS patients (Croxson et al., 1984; Frazer et al., 1986) . Along with viruses in the herpes family, HPV has been reported in lesions of oral HL (see "Epstein-Ban-virus" above) (Greenspan et al., 1985) . S.E. MLLER AND D.N. HOWELL Fig. 6 . a: HPV in the nucleus of a n infected cell. Small nondescript particles occasionally align in a crystalline array. b: High magnification of nondescript nuclear particles. c: Negative stain of bovine papillomavirus; the virion appears knobby or warty. Note the similarity to JCV and BKV. Bar in a = 1pm. Bar in b = Virus components can be detected by immunolabeling (Banks et al., 1987) or in situ hybridization (Gupta et al., 1987a; Wickenden et al., 1985) . However, diagnosis is usually made by routine histology of the excised lesion. Histological characteristics of warts include epidermal hyperplasia, hyperkerato- sis, cytoplasmic vacuolization with eosinophilic inclusions, and excessive nuclear basophilia (Murphy et al., 1984) .

Papillomaviruses can be detected by EM, though it is not generally used in the clinical diagnosis of warts. EM of negatively stained wart viruses shows knobby, 45-nm icosahed- rons (Fig. 6c) . In thin sections, the virus appears in the nuclei of cells as 45-nm dense spherical particles, sometimes in crystalline arrays (Fig. 6a,b) . Nuclear virus particles must be differentiated from nuclear granules, a nonspecific clumping of chromatin resulting from cell injury (Fig. 7) . Viruses are uniform in size and have a distinct round shape; nuclear granules are not as uniformly sized or shaped. The ultrastructure of warts and inclusion bodies is described by Almeida (1962) . LM and EM of malignant lesions are described by Kovi et al. (1974) ; however, the nuclear densities described are of questionable viral nature. Warts caused by papillomavirus should be differentiated from the "carcinoma-like" Buschke-Lowenstein tumor, as the latter is not responsive to podophyllin (Kovi et al., 1974) .

Because of their potential for malignancy, venereal warts should be removed; this can be achieved by topical treatment with 25% podophyllin in benzoin. Cancer treatment must be directed at the tumor, rather than the virus, and includes surgery and radiation (Kovi et al., 1974) .

Adenoviruses can cause a number of respiratory illnesses and conjunctivitis in immunocompetent patients; they can also be found in individuals without evidence of disease (Taylor, 1977) . They are not usually seen in the urine of healthy individuals CHonvitz et al., 1984) . Adenoviruses have been isolated from patients with AIDS (Gotlieb et al., 1981; Honvitz et al., 1984; Siegal et al., 1981) . In one case of encephalitis in an AIDS patient with dementia and spastic quadriparesis, adenovirus was isolated from CSF (Horoupian et al., 1984) , but the causal relationship of the virus to brain degeneration is unknown. Virus can be isolated from urine in up to 20% of AIDS patients (De Jong et al., 1983) and has also been isolated from stool (Armstrong et al., 1985) . The significance of adenovirus infection to disease or immunodeficiency in AIDS is not known, but strains 34 and 35 have been suggested to be cofactors in the syndrome (Horwitz et al., 1984) .

Many of the human adenovirus strains are common, and infection early in life is frequent (Hierholzer et al., 1982; De Jong et al., 19831 , making serology of no use in diagnosis. Cultural isolation is difficult from urine, which provides a hostile environment for virus survival, but some strains can be isolated from other locations. Certain strains are difficult to culture under any circumstances. Hybridization techniques (Horwitz et al., 1984; Engler and Kilpatrick, 1981) and EM can be used to detect the virus. By LM, inclusions in the nuclei of infected cells stain densely (Malherbe and Strickland-Cholmley, 1980) . Adenovirus-infected cell cultures exhibit a CPE consisting of cellular rounding and clumping (Hsiung, 1982) . By EM, the virus is a 75-nm naked icosahedron; triangular facets resembling a geodesic dome can often be seen in negative stains (Fig. 8b) . In thin sections, the flat, faceted sides sometimes align, creating a crystalline array. A DNA virus, adenovirus is found in the nucleus (Fig. 8a,c) . No treatment has been described for adenovirus infections.

A poxvirus causes molluscum contagiosum, a sexually transmitted papular skin lesion, which in immunocompetent individuals is usually self-limiting and resolves spontaneously in 3-12 months. In AIDS patients, the disease is more extensive and often occurs on the face (Redfeld et al., 1985) . In the absence of exogenous immunosuppression, extensive molluscum lesions in unusual locations with unusually rapid recurrence despite diligent therapy suggest AIDS (Katzman et al., 1985; Lombardo, 1985; Sarma and Weilbaecher, 1985) . The disease must be differentiated from cutaneous cryptococcosis with hypopigmented papules (Rico and Pen- neys, 1985) and cutaneous CMV infection (Penneys and Hicks, 1985) .

Characteristic histology includes epithelial hyperplasia and downward lobular growth of epidermal cells. The "molluscum body" in the stratum granulosum and stratum cor-tively stained preparations, the agent is a large brick-shaped virus measuring 200-250 nm by 200-250 nm by 300-350 nm; a representative poxvirus is shown in Figure 9 . It is neum is a large homogeneous cytoplasmic containing virus (Katzman et 1985) . In H 8~ E-stained sections, molluseum bodies within deeper epithelial strata are eosinophilic, while those in more superficial cells are basophilic. me CPE of poxvirusinfected cell cultures includes multinucleated cells (Hsiung, 1982) . By EM of nega-easily distinguishable from the spherical herpesviruses, a fact of potential value in the differentiation of molluscum lesions from HSV blisters or the lesions of shingles. In thin sections, poxvirus appears in the cytoplasm of cells as a large oval body with a dense coat (Fig. 9a-e) ; mature particles have a condensed core in the shape of a dumbbell (Fig. 9d,e) . Negative staining shows a rough brick-shaped virion (Fig. 90 .

Treatment of molluscum contagiosum is by curettage or cryotherapy of lesions. There is no drug treatment presently available, though acyclic and carbocyclic adenosine analogues such as neoplanocin A have shown promise against poxvirus as well as other viruses (De Clercq, 1986) .

Coronaviruses have been seen associated with enteric infections (MacNaughton, 1982; Chany et al., 1982; Vaucher et al., 19821, but they have also been demonstrated in some apparently healthy individuals (Maass and Baumeister, 1983) . Some strains have been associated with cold symptoms (McIntosh, 1974; Larson et al., 1980) . Coronavirus particles have been demonstrated in stool samples from AIDS patients and in the serum of one patient with lymphadenopathy syndrome (LAS) and diarrhea. They were seen in only 3 of 20 healthy homosexual males, and were not seen in healthy heterosexuals (Kern et al., 1985) . Although coronaviruses have been associated with disease in both normal individuals and AIDS patients, they do not appear to be a major contributor to morbidity and mortality in either group. An ELISA has been described for detection of coronavirus (MacNaughton, 1982) . In negative stains for EM, coronaviruses are membraned pleomorphic particles studded with 20-nm club-like spikes (Fig. 1Oc) . The nucleocapsid is nondescript. In thin sections, virions can be seen within or budding into the cisternae of endoplasmic reticulum (Fig.  10a,b) (Becker et al., 1967) .

No treatment has been described for coronavirus infection.

Parvovirus or noncultivable picorna-or parvovirus-like (NCPP) particles have been seen in children with AIDS; detection was by hybridization and serology (Wainberg and Mills, 1985) . However, no role in AIDS has been suggested for these agents (Anderson et al., 1985) .

Human T-lymphotropic virus type I (HTLV-I) is a lymphotropic retrovirus that causes malignant transformation, rather than depletion, of helper T cells. It is the etiologic agent of a form of T cell leukemia endemic in portions of Japan and the Caribbean, but not frequently encountered elsewhere (Catovsky et al., 1982; Haynes et al., 1983; Poiesz et al., 1980; Tajima et al., 1979) . HTLV-I has been isolated from several AIDS patients (Getchell et al., 1987; Harper et al., 1986; Kanner et al., 1987; Palmer et al., 1983) . Gallo suggests that the virus may advance the progression of AIDS (Edwards, 1987) . The morphology of HTLV-I is described by Palmer and Goldsmith (pp. 3-15) and Shamoto et al. (1981) .

Since its initial description, human immunodeficiency virus (HIV) has been established as a necessary factor in the pathogenesis of AIDS Montagnier et al., 1984; Montagnier, 1986; Sarngadharan et al., 1985) . The central etiologic role of HIV notwithstanding, numerous questions remain regarding other potential contributing factors in the development of the disease. Chief among these are the following:

1. Are additional external influences, particularly other viral infections, necessary prior or subsequent to exposure to HIV for the development of AIDS? 2. Do genetic factors, both in the virus and the host, influence susceptibility t o AIDS?

3. Will all individuals infected with HIV subsequently develop overt AIDS, or do some eliminate the virus or maintain it in a perpetual equilibrium similar to that seen for the herpesviruses?

In addition to HIV, numerous exogenous factors have been suggested to be necessary for, or at least conducive to, the development of AIDS. Several modes of action have been proposed for these cofactors, including induction of activated lymphocytes, the primary target cells of H N infection (Montagnier et al., 1984) ; facilitation of HIV infection via immunosuppression; and reactivation of latent HIV infection. The evidence for cofactors in the etiology of AIDS is derived largely from epidemiologic and in vitro studies. Firm establishment of an etiologic role for any given factor has been hampered by the lack of a suitable animal model for AIDS; chim- panzees can be infected with HIV and make antibodies to the virus, but they fail to develop subsequent immunodeficiency.

Numerous studies have implicated HBV as a cofactor in AIDS. Most patients with AIDS are serologically positive for HBV (Elfassi et al., 1984; Rustigi et al., 1984; Noonan et al., 19861, HBV infection are similar . Newly diagnosed AIDS victims frequently possess high-titered antibodies to HBcAg and HBsAg, suggesting that HBV infection antedated the development of AIDS.

HBV is lymphotropic; HBV DNA has been demonstrated in peripheral blood cells and bone marrow from numerous patients (Ro-met-Lemonne et al., 1983; Elfassi et al., 1984; Yoffe et al., 1986) , including patients with AIDS (Laure et al., 1985; Lie-Injo et al., 1985; Noonan et al., 1986) . Indeed, peripheral blood mononuclear cells from AIDS patients contain HBV DNA more frequently than those from hepatitis patients without AIDS, though it is not known whether this fact reflects a predisposition to AIDS in individuals infected with HBV or a n increased susceptibility to HBV infection in individuals with AIDS.

Most homosexuals in high-risk groups for AIDS have been exposed to CMV, EBV, and HSV; these agents have likewise been proposed as possible AIDS cofactors. CMV infection can cause extended immunosuppression and is frequently associated with lowered helperhuppressor T cell ratios (Giraldo and Beth, 1986; Rapp, 1984; Schechter et al., 1985) . In addition to a possible etiologic role in AIDS itself (Drew, 1986) , CMV has been strongly implicated as a cofactor in Kaposi's sarcoma (see above).

EBV has been reported to decrease helper/ suppressor T cell ratios (Schechter et al., 1985) as well as T cell cytotoxicity against EBV-infected target cells (Ragona et al., 1986) . A role for EBV in AIDS-related complex (ARC) has been proposed (Ragona et al., 1986; Rinaldo et al., 1986; Schechter et al., 1985) ; symptoms of ARC, including anorexia, malaise, fatigue, and night sweats, frequently resolve in parallel with declining anti-EBV antibody titers (Gervais et al., 1983 (Gervais et al., -1984 . EBV is also a potent transforming agent, and has been implicated as a possible etiological factor in several malignancies (see above).

HSV, JCV and other DNA viruses have been shown to augment HIV gene expression in vitro Mosca et al., 1987) . The disparate nature of these viruses has led to speculation that their common inductive effects on HIV may be mediated indirectly via host cellular mechanisms.

In spite of these observations, the role of viruses other than HIV as cofactors in AIDS is by no means firmly established. The epidemiologic evidence, in particular, is complex and occasionally contradictory. CMV and HSV, though commonly encountered in patients with sexually acquired AIDS, are less prevalent in hemophiliacs and children who contract the disease by hematogenous exposure to HIV and are uncommon in trop-ical areas where AIDS is nonetheless endemic (Blaser and Cohn, 1986) . Proponents of viral cofactor theories counter that many hemophiliacs have serologic evidence of exposure to herpesviruses and HBV (Landay et al., 1983; Sullivan et al., 1986) ; that in others, factor VIII injections may have immunosuppressive properties which provide a n alternative predisposition to HIV infection (Verani et al., 1986) ; and that HIV-seropositive hemophiliacs, including some with high anti-HIV antibody titers (Volsky et al., 19861, may indeed have a lower frequency of overt AIDS than seropositive homosexual men (Sullivan et al., 1986) . Likewise, many children with AIDS, including infants, have evidence of EBV infection Rubinstein, 1983; Scott et al., 1984) ; and the immunological immaturity of neonates could conceivably provide a n alternative to viral cofactors in the facilitation of HIV infection (Rubinstein, 1983) . The inability of the immune system in childhood to mount a full response to HIV infection is illustrated by the observation that some asymptomatic children who harbor HIV lack serologically detectable anti-HIV antibodies (Borkowsky et al., 1987; Pahwa et al., 19861 , and that the seropositive infants with ARC lose antibody response to HIV by age 10 months (Mok et al., 1987) .

Other exogenous factors initially suggested as cofactors in AIDS, such as illicit drug use, increased number of male sexual partners, and frequent receptive anal intercourse, do not seem to have a direct role in the pathogenesis of the disease. These factors appear to operate by increasing the probability of exposure to HIV (Schechter et al., 1985) .

Development of overt AIDS may be a function of genetics-both of the infecting HIV strain and of the human host. Several AIDScausing viruses with considerable genetic and virulence variation have been isolated (Barin et al., 1985; Coffin, 1986; Edwards, 1987; Ratner et al., 1985; Shaw, 1984) . A relationship between clinical severity of HIV infection and in vitro replication potential of the virus has been demonstrated (Asjo et al., 1986) . Different types of HIV varying with respect to growth rate and severity of cytopathological effect (CPE) have been reported (Riibsamen-Waigmann et al., 1986) . Two HIV variants with different DNA restriction maps were seen in one patient, suggesting either antigenic variation or superinfection by one of the two strains. Sodroski et al. (1986) suggest a mechanism for regulation of latent and lytic phases of the virus life cycle. See for a review of HIV genetics and the contribution of EM to that knowledge.

Regarding host genetic susceptibility, one study suggests that some individuals have lymphocytes that can suppress HIV activity (Walker et al., 1986) . Genetic studies of AIDS patients with KS have shown an increase in histocompatibility antigen DR5 and a decrease in DR3 (Giraldo et al., 1984) . It has also been speculated that HIV, which adheres to T lymphocytes via the CD4 molecule, induces the production of antibodies that crossreact with the endogenous CD4 ligand, thus interfering with lymphocyte communications necessary for normal immune responses (Stricker et al., 1987; Ziegler et al., 1986) .

As of yet, it is unclear whether HIV infection is occasionally compatible with survival for a normal life span or invariably leads to premature demise. The factors that delimit HIV-positive asymptomatic individuals from victims of overt AIDS have not been clearly identified (Valle et al., 1985) , though the wide variation in health status of HIV-seropositive individuals suggests that some may be capable of existing in equlibrium with the agent. It is estimated that approximately 30% of individuals infected with HIV develop AIDS within 5 years. Statistics are unavailable for the development of AIDS following longer latencies; estimates range as high as 70% or greater (M. Gonda, personal communication) .

In addition to its etiologic role in immunodeficiency, HIV is capable of directly infecting the CNS. Neurological HIV disease may precede immunodeficiency and is estimated to occur in 30-90% of AIDS victims (Berger, 1987; De la Monte et al., 1987; Purtilo et al., 1985) . Initial manifestations include acute or chronic meningitis, encephalitis, dementia, myelopathy, and peripheral neuropathy .

Encephalopathy is the most common HIVassociated neurologic disorder. Early symptoms are subtle and include mild progressive memory loss, generalized weakness with motor disturbances, and occasionally, seizures (Berger, 1987) . The presentation of HIV en-cephalopathy is frequently similar to those of opportunistic encephalitides, such as HSV and CMV encephalitis, PML, and CNS toxoplasmosis. Since some of these disorders are potentially treatable, every effort should be made to establish a definitive diagnosis. MRI is the noninvasive study of choice, and CSF can be examined for virus or antiviral antibodies.

Alternative presentations of HIV CNS disease are seen less frequently. HIV aseptic meningitis is occasionally encountered, sometimes in association with a mononucleosislike syndrome. Peripheral neuropathies may also occur; their manifestations include a motor disturbance resembling Guillain-Barre syndrome, pain, weakness, and autonomic neuropathy. The CSF is generally normal in HIV peripheral neuropathy. An associated myopathy of uncertain etiology, with weakness and electromyographic abnormalities, is occasionally seen (Berger, 1987) .

The current Centers for Disease Control surveillance case definition of AIDS relies partially, though by no means exclusively, on the presence of laboratory evidence for HIV infection (Centers for Disease Control, 1987) . A number of laboratory procedures for the detection of HIV have proven useful in the diagnosis of AIDS. However, a number of additional laboratory diagnostic procedures may be used to confirm the presence of AIDS and to detect HIV-associated CNS infection.

Many tests are available to detect antibody to HIV. Several ELISAs are commercially available and are relatively simple to perform; sensitivity is 97% or better, and specificity ranges from 70% to 100% (Gurtler et al., 1987; Sarngadharan et al., 1984; Weiss et al., 1985) . Western blot analysis is generally used for confirmation of the presence of anti-HIV antibodies, though it is more labor intensive than routine serological tests (Towbin et al., 1979) . Western blot tests generally correlate with the presence of virus, and antibody titers correlate with the progression of AIDS (Casareale et al., 1984 (Casareale et al., -1985 . However, the value of serological testing for HIV is decreased somewhat by the fact that some virus-positive individuals are antibody negative and that many presently healthy individuals are known to have anti-HIV antibodies Salahuddin et al., 1984) .

Biochemical assays can detect the presence of HIV by identifying a specific viral enzyme, reverse transcriptase (RT), not seen in unin-fected cells (Poiesz et al., 1980) ; assays for proviral DNA are also available (Gelmann et al., 1983) . Other detection systems for viral components include dot-blot hybridization, antigen capture, and radioimmunoassay (Monroe et al., 1987; Gupta et al., 1987b) . The virus itself has been isolated from peripheral blood cells after activation or cocultivation with susceptible cells Levy et al., 1984; Popovic et al., 1984) and has been isolated from CSF (Ho et al., 1985) . LM of HIV-infected brain tissue shows multinucleated giant cells; foamy macrophages, necrosis, perivascular inflammation, and demyelination may also be present (Berger, 1987; De la Monte et al., 1987) . Immunoperoxidase staining shows viral antigens in many different cell types (Ward et al., 1987) . LM can also be used to demonstrate CPE of HIV on leukocyte cultures (Rubsamen-Waigmann et al., 1986) .

HIV is not seen routinely by EM in lymphocytes from patients with AIDS unless they are first activated or cocultivated with susceptible tissue culture cells or stimulated with growth factors Montagnier et al., 1984) . The virus has been seen directly by EM in brain biopsies in oligodendroglia, astroglia, macrophages, and macrophage-like multinucleated cells, as well as extracellular spaces, capillary lumens, and endothelial gaps (Epstein et al., 1984 (Epstein et al., -1985 Gyorkey et al., 1987; Koenig et al., 1986; Wiley et al., 1986) ; and it has been seen in germinal centers of lymph nodes (Hammar et al., 1984; Warner et al., 1986) . EM techniques that have been used to detect HIV include examination of thin sections of infected tissue, scanning electron microscopy of infected cells, and negative staining of purified virus (Tsuchie et al., 1986) , as well as immunogold labeling of HIV-infected cell cultures (Pekovic et al., 1986) . Electron microscopic morphology of the virus is discussed in detail by and Schupbach et al. (1984) .

Treatment of AIDS has been attempted with a number of antiviral agents. Indeed, the AIDS epidemic has done much to spur the rapid development of drug therapies for both AIDS itself and its opportunistic complications. Several drugs have been shown to have in vitro activity against HIV, but their clinical efficacy has been variable.

Azidothymidine (AZT), which inhibits HIV replication and CPE, is the only drug cur-rently on the market for AIDS. The molecular mechanism of action of AZT is described by Yarchoan and Broder (1986) . Side effects are headache, neutropenia, and anemia. Acyclovir, an antiherpetic agent, can potentiate the antiretroviral action of AZT, but the mechanism of potentiation is unknown (Yarchoan and Broder, 1986) .

Suramin (Germanin), in human use already for trypanosomiasis and onchocerciasis, inhibits HIV in vitro. However, its efficacy in vivo is equivocal, and its use is associated with a high incidence of adrenal insufficiency, rash, fever, and liver and other toxicities (FDA, 1985; Tuazon and Labriola, 1987) .

Ribavirin has been used successfully in the treatment of some RNA virus infections, including influenza A, and shows in vitro activity against HIV. In vivo, it decreases viral RT activity in lymphocytes, but does not eliminate the virus. Reversible side effects include anemia, nausea, headache, and mental status changes. Humal trials are continuing (FDA, 1985; Tuazon and Labriola, 1987) .

Antimoniotungstate (HPA-23) is active in vivo in animals against a broad range of RNA and DNA viruses and inhibits the RT of HIV. Initial studies showed virus elimination in some patients with a reappearance of viremia after discontinuation of the drug. Other patients had no clinical improvement. Thrombocytopenia, liver dysfunction, and fever are side effects. Further clinical trials are in progress (FDA, 1985; Tuazon and Labriola, 1987) .

Phosphonoformate inhibits the DNA polymerases of human herpesviruses and has been used topically in the treatment of CMV retinitis and herpes mucocutaneous lesions.

It also inhibits the RT of retroviruses. Clinical trials in AIDS and ARC patients are underway in Denmark and Sweden. The main side effect of phosphoformate is kidney toxicity (FDA, 1985; Tuazon and Labriola, 1987) . DHPG, effective against CMV, also has some in vitro activity against HIV and is in clinical trials. Ansamycin and several other drugs that have in vitro activity against HIV are being prepared for clinical trials (FDA, 1985; De Clercq, 1986) .

Other avenues of potential therapeutic strategy include passive treatment with immune globulin; reconstitution of the immune system by bone marrow transplantation or lymphocyte transfusion; and enhancement of the immune system with immunomodulators, including endogenous substances such as CY and y interferon, interleukin-2, thymosin, and transfer factor, and exogenous agents such as ampligen, inosine pranobex (isoprinosine), and imuthiol (Bolognesi and Fishinger, 1985; Carter, et al., 1987; Lane et al., 1985; Sheridan et al., 1984; FDA, 1985; Hopkins, 1985; Pompidou et al., 1985; Tuazon and Labriola, 1987) . Reconstitution has thus far been unsuccessful; before this treatment will work, measures must be developed to prevent the transplanted cells from becoming infected with HIV. Successful therapy of AIDS may eventually rely upon a combination of immunomodulatory and antiviral approaches.

Prior to the identification of HIV, ultrastructural research on the etiology of AIDS yielded a number of candidates for the causative agent. The identity of many of these particles has since been elucidated. Some are actually virions present as opportunistic infections; others are either subcellular organelles or artifacts; still others are viral-induced but nonspecific changes.

The most frequently reported observation has been of tubuloreticular structures (TRS) or tubulorecticular inclusions (TRD see Tucker, pp. 137-158), seen mainly in lymphocytes (Feremans et al., 1983; Orenstein, 1983; Schaff et al., 1983; Schenk et al., 1986; Sidhu et al., 1983; Thune et al., 1983; Watanabe et al., 1984; Zucker-Franklin, 1983) , but also in the choroid of the eye (Jensen, 19851, endothelial cells in Kaposi's sarcoma, and fibroblasts (Zucker-Franklin, 1985) . These "wormlike" inclusions resemble nucleocapsids of myxoviruses, though TRS are slightly larger in diameter (25 nm vs. 9-18 nm) (Fig. lla,c,d) . Similar structures have been described in the kidneys of patients with systemic lupus erythematosus (SLE), and have been seen in other diseases and in drug-treated cells (Sinkovics et al., 1969; Grimley et al., 1973; Grimley and Schaff, 1976; Schaffet al., 1982) . Larger rod-like structures measuring 65 x 143 nm have been described in a lymphoid line from an infant with AIDS (Burrage et al., 1984) . TRS contain lipid and acidic glycoprotein, but not nucleic acid (Sidhu and Waisman, 1985) .

The factors that predispose to the development of TRS are obscure. Antibodies against HTLV-I and (perhaps crossreacting) antibodies against HTLV-I11 have been identified in individuals with SLE (Olsen et al., 19871 , raising the possibility of retroviral infection in such patients and providing a plausible explanation for ultrastructural similarities between AIDS and SLE. TRS have also been related to interferon exposure (Rich, 1981) .

Membranous structures designated as test tube and ring-shaped forms (TRF), cylindrical confronting cisternae (CCC), or cylindrical confronting lamellae (CCL) have been seen in many AIDS patients (Fig. llb,c) (see Tucker, . They appear to be concentric arrangements of endoplasmic reticulum with alayer of electron-dense material interposed between them; they may be up to 3.5 pm long and 250 nm in diameter (Kostianovsky et al., 1987; Sidhu et al., 1983) . Similar inclusions have been seen in other diseases, such as adult T cell leukemia and other neoplasms, multiple sclerosis, and SLE, as well as virus-infected cells (Shamoto et al., 1981; Prineas, 1978; Hammar et al., 1984) . TRF can be differentiated from the simple paired cisternae seen in stimulated cells (Kostianovsky et al., 1987) . Continuity between TRS and TRF has been seen (Fig. llc) , and both are probably the result of membrane proliferation, perhaps caused by viral infection or other stimulation (Feremans et al., 1983; Hammar et al., 1984; Kostianovsky et al., 1984; Schaff et al., 1983) .

Another membranous structure composed of 70-nm vesicles within a larger membrane has been described in lymphocytes of AIDS patients (Fig. lle) (Feremans et al., 1983) . Gardiner et al. (1983) have suggested that these organelles represent multivesicular bodies (MVB) similar to those seen in normal (Brown et al., 1983; Ghadially, 1982) and activated (Grossi et al., 1983) lymphocytes. However, in a later publication, Feremans et al. (1984) described the immunolabeling of large cytoplasmic vacuoles resembling MVB in 1% of mononuclear cells from an AIDS patient; the antibodies used were against HTLV-I and bovine leukemia virus followed by secondary antibodies conjugated to colloidal gold. The authors speculated that the labeled material consisted of H N antigens that cross-reacted with antibodies against core proteins of related viruses. Vesicular rosettes have been described in lymphocytes of AIDS patients. These bulbous membrane structures are 300-500 nm in diameter and contain 30-to 60-nm vesicles ( Fig. 110 (Ewing et al., 1983) . They have also been seen in other situations (Miller and Fig. 11 . Virus-like structures and unusual ultrastructure reported in AIDS patients. a: TRS 20 nm in diameter b:TRF composed of rough endoplasmic reticulum enclosing dense material, cut in longitudinal (small arow) and cross (large arrow) section. c:TRF with TRS in the lumens. d: TRS together with vacuoles resembling MVB. e:"Virus-like" structures (V) inside a cytoplasmic vesicle. This structure resembles MVB and the vesicle in d. fi Vesicular rosette in the cytoplasm composed of smaller vesicles. g: Virus-like particles in phagocytosed debris within a histiocyte. h: Intracytoplasmic particles in a n epithelial cell from the same patient as that in g.

i: Extracellular "virus-like" vesicles from tissue culture cells cocultivated with AIDS material. All bars = 1 W m except the inset in g and h, which = 100 nm. a and c are reprinted from Sidhu et al. (19831, with permission from The Lancet; b and d are from Orenstein (1983), with permission from The Lancet; e is from Feremans et al. (1983) , with permission from The Lancet; f is from Ewing et al. (19831, with permission from The New England Journal of Medicine; g and h are from Chandler et al. (19841, with permission from the Annals of Internal Medicine; i is from Lo (1986) , with permission from the American Journal of Tropical Medicine. Rogers, 1984) , and their distinction from multivesicular bodies or lysozomes has been questioned (Zucker-Franklin, 1983) .

Unidentified particles of 45-55 nm with an electron-dense core have been reported in intestinal epithelial cells of AIDS patients (Fig.  llg,h) . They were seen predominantly within membrane-bound cytoplasmic vacuoles and in phagocytosed debris, but occasionally were observed extracellularly. The authors speculated that they differed from previously reported breakdown products (Chandler et al., 1984) .

Virus-like particles 140-280 nm in diameter enclosing 8-to 9-nm diameter tubular structures resembling nucleocapsids (Fig. lli) have been seen both intra-and extracytoplasmically in a mouse cell line transfected with DNA from a patient with AIDS, but not in nontransfected cells (Lo, 1986) . These structures do not resemble known viruses, and in the single published micrograph, it is difficult to distinguish them from cell processes.

The importance of an understanding of viral processes in patients with AIDS cannot be overemphasized. For the present time, opportunistic viral infections account for a large portion of the morbidity and mortality experienced by such patients. The tempo of viral infection in individuals with AIDS is often swift, and demands rapid and accurate diagnostic approaches. Therapy for viral infections in AIDS patients, though currently far from satisfactory, is of some benefit, and is the focus of intense investigation.

In the future, elucidation of the pathogenesis of AIDS and the ultimate conquest of the disease will rest at least in part on an understanding of viral mechanisms. It is anticipated that the investigative modalities described above will play a major role in this understanding. Barin 

rus cholangitis in a homosexual man with acquired immune deficiency syndrome

Practical aspects of diagnostic electron microscopy

Electron microscopic study of human warts; sites of production and nature of inclusion bodies

Agar diffusion method for negative staining of microbial suspensions in salt solutions

Specific identification of enteroviruses by immuno-electron microscopy using serum-in-agar diffusion method

Parvovirus infection and the ac

Acyclovir treatment in infectious mononucleosis: a clinical and virological study

Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS

Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases

Serologic studies of papovavirus infections in pregnant women and renal transplant recipients

Treatment of infections in patients with the acquired immunodeficiency syndrome

Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection

Breakthrough of cytomegalovirus infection despite 9-(1,3-dihydroxy-2-propoxymethyl)guanine therapy

Cytomegalovirus colitis in AIDS: Radiographic findings in 11 patients

Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas

Acquired immunodeficiency syndrome of childhood

Enhanced enzyme immunoassay for the detection of hepatitis B surface antigen

Use of the transbronch'lal biopsy for diagnosis of opportunistic pulmonary infections in acquired immunodeficiency syndrome (AIDS)

Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies

Prospects for treatment of human retrovirus-associated diseases

Human-immunodeficiency-virus infections in infants negative for anti-HIV by enzyme-linked immunoassay

Nucleic acid spot hybridization: Rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA

A new complication of AIDS: Thoracic myelitis caused by herpes simplex virus

Progressive multifocal leukoencephalopathy

Recycling receptors: The round-trip itinerary of migrant membrane proteins

Papovavirus antigens in paraffin sections of PML brains

Virus-like rods in a lymphoid line from an infant with AIDS

Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA

-1985) Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals a t risk for AIDS in Greenwich Village

Adult T-cell lymphoma-leukaemia in blacks from the West Indies

Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome

Unidentified virus-like particles in the intestine of patients with the acquired immunodeficiency syndrome

Herpes zoster and its neurological complications

Association of coronavirus infection with necrotizing enterocolitis

Herpes simplex viral hepatitis in adults: Two case reports and review of the literature

Persistence of DNA sequences of BK virus and JC virus in normal tissues and diseased tissues

Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridization

Malignant lymphomas, AIDS, and the pathogenetic role of Epstein-Barr virus

Genetic variation in AIDS viruses

Herpes zoster ophthalmicus 'and acquired immune deficiency syndrome

Human polyomaviruses in pregnancy. A model for the study of defence mechanisms to virus reactivation

Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

Herpes zoster and the acquired immunodeficiency syndrome

Intraepithelial carcinoma of the anus in homosexual men

Current leads in antiviral chemotherapy

Adenovirus isolates from the urine of patients with acquired immunodeficiency syndrome

Subacute encephalomyelitis of AIDS and its relation to HTLV-I11 infection

Cytomegalic inclusion retinitis in an adult

Electron Microscopy in Diagnostic Virology

Human cytomegalovirus infection: Recent developments in diagnosis and epidemiology

Simple mathematical deductions in the seroepidemiology of viral infections. I. Herpesvirus group (herpes virus hominis, varicella-zoster-virus, cytomegalovirus, Epstein-Barr-virus)

Diagnostic potential of IgA class and IgG sub-class-specific antibodies

Kaposi's sarcoma, chronic ulcerative herpes simplex, and acquired immunodeficiency

Is cytomegalovirus a cofactor in the pathogenesis of AIDS and Kaposi's sarcoma?

Prevalence of cytomegalovirus infection in homosexual men

Cytomegalovirus infection of the adult nervous system

D. i1987) New virus, growth factor found for

Cytomegalovirus meningoencephalitis in a homosexual man with Kaposi's sarcoma: Isolation of C M V from CSF cells

Evidence of extrachromosomal forms of hepatitis B viral DNA in a bone marrow culture obtained from a patient recently infected with hepatitis B virus

Factors affecting the detection of cytomegalovirus in urine by sandwich enzyme immunoassays

A submucosal antral mass caused by cytomegalovirus infection in a patient with acquired immunodeficiency syndrome

Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies

Cloning and characterization of class B adenoviruses Ad 3 and Ad 7 DNA

Recent progress in Epstein-Barr virus research

Morphology of the virus and of virus-induced cytopathologic change

-1985) HTLV-III/ LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy

Unusual cytoplasmic body in lymphoid cells of homosexual men with unexplained lymphadenopathy. A preliminary report

Epstein-Barr virus infection in a child with acquired immunodeficiency syndrome

FDA (1985) Progress on AIDS

Kaposi's sarcoma following chemotherapy for testicular cancer in a homosexual man: Demonstration of cytomegalovirus RNA in sarcoma cells

Virus-like particles in lymphocytes of seven cases of AIDS in black

Ultrastructural demonstration of retrovirus antigens with immuno-gold staining in prodromal acquired immune deficiency syndrome

Latent papillomavirus and recurring genital warts

Prevention of heroes simdex virus infections in susceptible patients. IGection, i 5

Light and electron microscopy of virus-infected cells

Cytomegalovirus colitis in acquired immune deficiency syndrome: Radiologic spectrum

Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men

Cytomegalovirus esophagogastritis in a patient with acquired immunodeficiency syndrome

Herpes zoster: A possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals

Treatment of infectious complications of acquired immunodeficiency syndrome

Frequent detection and isolation of cytoplasmic retroviruses (HTLV-111) from patients with AIDS

HTLV-I11 and the etiology of AIDS

Widespread cytomegalovirus infection involving the gastrointestinal tract, biliary tree, and gallbladder in an immunocompromised patient

Virus-like particles" in lymphocytes in AIDS are normal organelles

Proviral DNA of a retrovirus, human T-cell leukemia virus

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses

-1984) Natural history of the AIDS related complex in hemophilia: Relationships to Epstein-Barr virus

Detection of human T cell leukemia virus type I and human immunodeficiency virus in cultured lymphocytes of a Zairian man with AIDS

Ultrastructural Pathology of the Cell and Matrix

Varicella-zoster virus infection of human mononuclear cells

The involvement of cytomegalovirus in acquired immune deficiency syndrome and Kaposi's sarcoma

Role of cytomegalovirus in Kaposi's sarcoma

Comparison of standard tube and shell vials culture techniques for the detection of cytomegalovirus in clinical specimens

Clinical spectrum of infections in patients with HTLV-111-associated diseases

Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome

Monoclonal antibodies to cytomegalovirus: Rapid identification of clinical isolates and preliminary use in diagnosis

Molecular genetics and structure of the human immunodeficiency virus

Staining qualities of cytomegalovirus inclusions in the lungs of patients with the acquired immunodeficiency syndrome: A potential source of diagnostic misinterpretation

Pneumocys tis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency

Oral "hairy" leukoplakia in male homosexuals: Evidence of association with both papillomavirus and a herpesgroup virus

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDSassociated lesion

Microbial pathogenicity in oral soft tissue diseases

Rapid diagnosis of cytomegalovirus infection

Induction of tubular structures in the endoplasmic reticulum of human lymphoid cells by treatment with 5-bromo-2'-deoxyuridine

Significance of tubuloreticular inclusions in the pathobiology of human disease

Antibody seronegative human T-lymphotropic virus type I11 (HTLV-IIItinfected patients with acquired immunodeficiency syndrome or related disorders

Ultra-structural characteristics of human T-cell clones with various cytolytic activities

Acquired immune deficiency syndrome: Postmortem findings

Detection of human immunodeficiency virus by reverse transcriptase assay, antigen capture assay, and radioimmunoassay

Human papillomavirus-associated early vulvar neoplasia investigated by in situ hybridization

Sensitivity and specificity of commercial ELISA kits for screening anti-LAVMTLV-111

14q+ abnormality with probable t(8;14) (q24;q32) in a young Haitian immigrant with acquired immunodeficiency syndrome and concomitant Burkitt's-like lymphoma

Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy

Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody

More on ultrastructure of AIDS lymph nodes

Radiculomyelopathy due to genital herpes

Concomitant infection with HTLV-I and HTLV-I11 in a patient with T8 lymphoproliferative disease

Cytomegalovirus encephalitis in acquired immunodeficiency syndrome

Fixation for Electron Microscopy

Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis

Herpetic proctitis and meningitis: Recovery of two strains of herpes simplex virus type I from cerebrospinal fluid

Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis

New human adenovirus associated with respiratory illness: Candidate adenovirus type 39

Cytomegalovirus infection of the alimentary tract: A clinicopathological correlation

Treatment of herpesvirus infections

Treatment of herpesvirus infections

Isolation of HTLV-I11 from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

Human polyomavirus infections with JC virus and BK virus in renal transplant patients

Ocular manifestations of the acquired immunodeficiency syndrome

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9

Clinical. A new approach to combat viruses

Acquired immunodeficiency syndrome and multiple tract degeneration in a homosexual man

Characterization of adenovirus isolates from AIDS patients

Diagnostic Virology Illustrated by Light and Electron Microscopy

Pathology of viral hepatitis

Cytomegalovirus DNA and adenocarcinoma of the colon: Evidence for latent viral infection

r(l986) The ophthalmological features of AIDS and AlDS related disorders

Cytoplasmic structures in endothelial cells of the choroid

Light microscopical, ultrastructural and immunohistochemical examination of a case

Simultaneous infections with human T cell leukemia virus type I and the human immunodeficiency virus

Immune electron microscopy as a method for the detection, identification and characterization of agents not cultivable in a n in vitro system

Molluscum contagiosum and the acquired immunodeficiency syndrome

Acalculous cholecystitis and cytomegalovirus infection in the acquired immunodeficiency syndrome

Detection of coronavirus-like particles in homosexual men with acquired immunodeficiency and related lymphadenopathy syndrome

Normalized enzyme-linked immunosorbent assay for detecting immunoglobulin G antibodies to cytomegalovirus

The relationship of the virus to nasopharyngeal carcinoma

Widespread cytomegalovirus gastroenterocolitis in a patient with acquired immunodeficiency syndrome

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

Ultrastructural and immunoelectron microscopic studies of cells with abnormal cytoplasmic inclusions in patients with AIDS

Cytomembranous inclusions observed in acquired immunodeficiency syndrome. Arch. Pathol

Treatment of disseminated cytomegalovirus infection with 9-(1,3-dihydroxy-2-propoxy-methy1)guanine: Evidence of prolonged survival in patients with the acquired immunodeficiency syndrome

Malignant transformation of condyloma acuminatum

The natural history and treatment of epidemic Kaposi's sarcoma

Progressive multifocal leukoencephalopathy: Clinical and radiographic features

Immunologic studies in asymptomatic hemophilia patients. Relationship to acquired immune deficiency syndrome (AIDS)

Therapeutic approaches to patients with AIDS

Isolation of rhinoviruses and coronaviruses from 38 colds in adults

Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS

Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex

Cytomegalovirus colitis in acquired immunodeficiency syndrome-a chronic disease with varying manifestations

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature

Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS

Hepatitis B virus (HBV) DNA in leucocytes in acquired immune deficiency syndrome (AIDS)

Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies

1983-1984) Epstein-Barr virus and chronic lymphadenopathy in male homosexuals with acquired immunodeficiency syndrome (AIDS)

Isolation and identification of a novel virus from patients with AIDS

Molluscum contagiosum and the acquired immunodeficiency syndrome

Coronavirus-like particles as aetiological agents of acute non-bacterial gastroenteritis in humans

Death in the AIDS patient: Role of cytomegalovirus

Occurrence and frequency of coronavirus infection in humans as determined by enzyme-linked immunosorbent assay

Acquiied immunodeficiency syndrome manifested by chronic primary genital herpes

Viral Cytopathology

Advances in the isolation of HTLV-I11 from patients with AIDS and AIDS-related complex and donors at risk. Cancer Res

AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families

Human papillomavirus and cervical cancer

Coronaviruses: A comparative review

Detection of cytomegalovirus in urine samples by enzyme-linked immunosorbent assay

Glial and divergent cells in primate central nervous system tumors induced by JC virus isolated from human progressive multifocal leukoencephalopathy (PML)

Report of the clinical, endoscopic, and pathologic findings in two patients with the acquired immune deficiency syndrome

Association of cytomegalovirus (CMV) infection with cervical cancer: Isolation of CMV from cell cultures derived from cervical biopsy

Detection and identification of viruses by electron microscopy

Rapid diagnosis of herpes simplex infection: Amplification for electron microscopy by short term in vitro replication

Ultrastructure in AIDS

Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency

Treatment of first-attack genital herpes-acyclovir versus inosine pranobex

Infants born to mothers seropositive for human immunodeficiency virus

Use of cytoplasmic dot-blot hybridization to detect human immunodeficiency virus RNA sequences in cultures of peripheral blood

Lymphadenopathy associated virus: Its role in the pathogenesis of AIDS and related diseases

Lymphadenopathy associated virus and its etiological role in AIDS

Herpes simplex virus type 1 can reactivate human immunodeficiency virus

Cytomegalovirus. Induced demyelination associated with acquired immmune deficiency syndrome

Comparison of cytomegalovirus infection of brain and lung in a patient with subacute encephalopathy of acquired immunodeficiency syndrome

The skin

Medical complications of herpes zoster in immunocompetent patients

Diagnosis of cytomegalovirus pneumonia by in situ hybridization

and the Collaborative Antiviral Study Group (1982) Herpes simplex virus encephalitis: Laboratory evaluations and their diagnostic significance

Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus

Pathologic features of the lung in the immunocompromised host

A test for human cytomegalovirus-specific immunoglobulins using a modification of a commercial test kit

Extrachromosomal sequences of hepatitis B virus DNA in peripheral blood mononuclear cells of acquired immune deficiency syndrome patients

Serological and virological evidence of human T-lymphotropic virus in systemic lupus erythematosus

Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg)

Ultrastructural markers in AIDS

New human papovaviruses

Virologic and serologic studies of progressive multifocal leukoencephalopathy

Spectrum of human T-cell lymphotropic virus type I11 infection in children: Recognition of symptomatic, asymptomatic, and seronegative patients

Ophthalmic involvement in acquired immunodeficiency syndrome

Treatment of cytomegalovirus retinitis with dihydroxy propoxyme-thy1 guanine

Ultrastructure of human retroviruses

Detection of two human T cell leukemidymphotropic viruses in cultured lymphocytes of a hemophiliac with AIDS

Shingles in seven homosexuals

Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma

Immunogold labeling of HTLV III/LAV in H9 cells studied by transmission electron microscopy

Unusual cutaneous lesions associated with acquired immunodeficiency syndrome

Immunocytologic localization of herpes simplex type 1 viral antigens in herpetic retinitis and encephalitis in an adult

An analysis of retinal cotton-wool spots and cytomegalovirus retinitis in the acquired immunodeficiency syndrome

Progressive multifocal leukoencephalopathy. Immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy

Small noncleaved B cell Burkitt-like lymphoma with chromosome t(8:14) translocation and Epstein-Barr virus nuclear-associated antigen in a homosexual man with acquired immune deficiency syndrome

Neuropathology of acquired immunodeficiency syndrome (AIDS): An autopsy review

Comparative evaluation of various techniques to detect EBV DNA in exfoliated nasopharyngeal cells

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous Tcell lymphoma

Isoprinosine and imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms

Detection, isolation, and continuous production of cytoplasmic retroviruses 1HTLV-111) from patients with AIDS and pre-AIDS

Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical, and pathologic correlation

Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis

Epstein-Barr virus as a n etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients

Herpesvirus infections in the acquired immune deficiency syndrome

Evidence for disregulation in the control of Epstein-Barr virus latency in patients with AIDS-related complex

Cytomegalovirus and carcinogenesis

HTLV-111, LAV; ARV are variants of &e same virus

Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients

Severe molluscum contagiosum infection in a patient with human T cell lymphotropic (HTLV-111) disease

Human lupus inclusions and interferon

Progressive multifocal leukoencephalopathy: Its pathological features

Cutaneous cryptococcosis resembling molluscum contagiosum in a patient with AIDS

Association of HTLV-I11 with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men

Cytomegalovirus: Detection in human colonic and circulating mononuclear cells in association with gastrointestinal disease

Unilateral cytomegalovirus retinochoroiditis and bilateral cytoid bodies in a bisexual man with the acquired immunodeficiency syndrome

Hepatitis B virus infection in cultured human lymphoblastoid cells

Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine

Primary central nervous system lymphoma related to Epstein-Barr virus in a patient with acquired immune deficiency syndrome

Sensitivity and specificity of enzyme immunofiltration and DNA hybridization for the detection of HCMV-infected cells

Acquired immunodeficiency syndrome in infants

Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC and AIDS

Hepatitis B virus infection in the acquired immunodeficiency syndrome

Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS

Cytomegalovirus hepatitis: Evidence for direct hepatic viral infection using monoclonal antibodies

HTLV-111 in symptom-free seronegative persons

Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS)

Evidence for the association of cytomegalovirus with carcinoma of the prostate

Molluscum contagiosum in the acquired immunodeficiency syndrome

HTLV-111: The etiologic agent of AIDS

Antibodies reactive with human T lymphotropic retrovirus (HTLV-III) in the serum of patients with AIDS

Radiologic techniques in the diagnosis of CNS infections

Occurrence of tubuloreticular inclusions in acute viral hepatitis

The Vancouver Lymphadenopathy-AIDS study: 4. Effects of exposure factors, cofactors and HTLV-111 seropositivity on number of helper T cells

Tubuloreticular structures in peripheral blood cells from patients with AIDS-associated Kaposi's sarcoma

Early diagnosis of herpes simplex encephalitis by MRI

Rapid cytologic diagnosis of cytomegalovirus interstitial pneumonia on touch imprints from open-lung biopsy

Serological analysis of a subprouo of human T-lvmuhotrouic retroviruses (HTLV-III) associated with AfDS: Science

Acquired immunodeficiency syndrome in infants

Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: Comparison with results for other viral markers

Adult T cell leukemia in Japan: An ultrastructural study

Sedimentation counting of particles via electron microscopy

Molecular characterization of HTLV-I11 in AIDS

Treatment of varicella-zoster virus infection in severely immunocompromised patients

Modulation of virus-specific immunity in vitro by the addition of interleukin-l and interleukin-2 in patients with the acquired immune deficiency syndrome

Adenosine monophosphate for the treatment of varicella zoster infections: A large dose of caution (Editorial)

Hepatitis B virus DNA in Kaposi's sarcoma

Panel discussion on tubuloreticular structures

Severe acquired immunodeficiency in male homosexuals manifested by chronic perianal ulcerative herpes simplex lesions

A rapidly fatal case of systemic lupus erythematosus: Structures resembling viral nucleoprotein strands in the kidney and activities of lymphocytes in culture

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

A second post-transcriptional trans-activator gene required for HTLV-111 replication

Cytomegalovirus-an update

The oncogenic potential of human cytomegalovirus

The use of DNA probes in studies of human cytomegalovirus

Breast milk and the risk of cytomegalovirus infection

J C papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy

An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells

Hemophiliac immunodeficiency: Influence of exposure to factor VIII concentrate, LAVMTLV-111, and herpesviruses

Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex

Protozoal infections in the acquired immunodeficiency syndrome

Geographical features and epidemiological approach to endemic T-cell leukemidymphoma in Japan

Isolation of a papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome

Adenoviruses: Diagnosis of infections

A review of the efficacy of adenosine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: Identification of factors influencing response rates

Acquired immune deficiency syndrome (AIDS) manifesting as anogenital herpes zoster eruption: Demonstration of virus-like particles in lymphocytes

Electrophoretic transfer of proteins from polyacryIamide gels to nitrocellulose sheets: Procedure and some applications

Budding process and fine structure of lymphadenopathy-associated virus (LAV)

Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects

Malignancies in the acquired immunodeficiency syndrome

Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome

Diversity of clinical spectrum of HTLV-111 infection

Pleomorphic, enveloped, virus-like particles associated with gastrointestinal illness in neonates

Prevalence of HTLV-IIYLAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX

Alpha interferon therapy of Kaposi's sarcoma in AIDS

HTLV-IIYLAV antibodies and virus in hemophilia patients in Nebraska: Survey and initiation of a prospective study

Progressive multifocal leukoencephalopathy: An opportunistic viral infection of the central nervous system

A. lvmuhocvtes can control HN infection in vitro by suppr&&g viral replication

Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections

Diagnosis of HTLV-I11 infection by ultrastructural examination of germinal centers in lymph node-a case report

Electron microscopic evidence of non-A, non-B hepatitis markers and virus-like particles in immunocompromised humans

Viral infections of the nervous system

Screening test for HTLV-I11 (AIDS agent) antibodies

Burkitt's lymphoma in AIDS

Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsyproven herpes simplex encephalitis

Screening for wart virus infection in normal and abnormal cervices by DNA hybridization of cervical scrapes

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

Rapid diagnosis of herpes simplex virus infections in conventional and shell vial cultures using monoclonal antibodies

Problems in the therapy of AIDS-associated malignancies

Oral acyclovir for acute herpes zoster infection in immune-competent adults

Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders

Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA

Comparison of seven enzyme immunoassay systems for measurement of cytomegalovirus

AIDS Otolaryngological presentation in the high-risk male homosexual

Hypercalcemia and disseminated cytomegalovirus infection in the acquired immunodeficiency syndrome

Outbreak of Burkitt's-like lymphoma in homosexual men

Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus

Looking" for the cause of

Panel discussion on tubuloreticular structures

Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy)

The authors wish to acknowledge the excellent technical assistance of Lynne Bartling. We thank the efficient and friendly staff of the Duke University Medical Center Library for their extensive help and also Dr. John M.